Main Menu

Maternal pneumococcal and influenza immunisation

Rating

Share

Digg! Reddit! Del.icio.us! Google! Live! Facebook! Slashdot! Netscape! Technorati! StumbleUpon! Spurl! Wists! Simpy! Newsvine! Blinklist! Furl! Fark! Blogmarks! Yahoo! Smarking! Netvouz! Shadows! RawSugar! Ma.gnolia! PlugIM! Squidoo! BlogMemes! FeedMeLinks! BlinkBits! Tailrank! linkaGoGo!

Info

Description

3rd March 2011

The first maternal pneumococcal vaccine trial was conducted in PNG in 1973 when 187 women, recruited for a larger vaccine trial, were subsequently found to be pregnant after vaccination. Since that time, maternal pneumococcal vaccine trials have now been conducted in Asia, Africa and North America but the total number of vaccines administered during pregnancy is modest.

The Papua New Guinea Institute of Medical Research recently hosted a colloquium titled “Action against pneumonia: a celebration of 40 years of pneumonia research in PNG and finding the best way forward”. Assoc Prof Ross Andrews was an invited speaker at the PNG colloquium where he provided an overview of the evidence base for pneumococcal vaccination in pregnancy and an update on the interim findings from a maternal pneumococcal vaccine trial that he is leading the NT. The NT study, called PneuMum, has just completed follow-up of 196 mother-infants pairs. Ross will be providing an update of his presentation at the PNG colloquium, a summary of the intermediate findings from the PneuMum study and an update of the current status of maternal influenza vaccination.

Presenter
Associate Professor Ross Andrews
Associate Director, Research and Education Division, Menzies School of Health Research

Tags
None